Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 3 Insider Initial Statement of Ownership
  4. 10-K Report Annual Report
  5. 8-K Event Other events
  6. 8-K Event Delisting notice
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change · Other events
  10. 8-K Event Material agreement
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 8-K Event Other events
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 4 Gift Chief Medical Officer gave 3,819,170 shares (gift)
  16. 10-Q Report Quarterly Report
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 8-K Event Delisting notice · Executive or director change
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 17 of 50 · 996 filings